Want to see KR:234080 full AI Analyst Report?
JW LIFESCIENCE CORPORATION (234080) Financial Statements
JW LIFESCIENCE CORPORATION Financial Overview
JW LIFESCIENCE CORPORATION's market cap is currently $162.74B. The company's EPS TTM is $1681.33; its P/E ratio is 6.25; and it has a dividend yield of 5.23%. JW LIFESCIENCE CORPORATION has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 257.83B | $ 222.48B | $ 206.86B | $ 188.93B | $ 169.82B |
| Gross Profit | $ 69.77B | $ 57.51B | $ 52.35B | $ 48.12B | $ 49.16B |
| Operating Income | $ 33.30B | $ 35.86B | $ 30.86B | $ 27.09B | $ 28.42B |
| EBITDA | $ 51.41B | $ 76.82B | $ 50.83B | $ 43.75B | $ 37.59B |
| Net Income | $ 28.61B | $ 43.99B | $ 28.14B | $ 14.96B | $ 12.91B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 10.49B | $ 9.62B | $ 28.35B | $ 28.87B | $ 5.08B |
| Total Assets | $ 318.21B | $ 325.32B | $ 255.84B | $ 252.94B | $ 219.47B |
| Total Debt | $ 50.57B | $ 69.24B | $ 46.31B | $ 67.20B | $ 46.49B |
| Net Debt | $ 42.19B | $ 61.73B | $ 26.09B | $ 63.28B | $ 41.56B |
| Total Liabilities | $ 97.63B | $ 124.88B | $ 96.44B | $ 112.61B | $ 87.97B |
| Stockholders' Equity | $ 220.58B | $ 200.44B | $ 159.39B | $ 140.33B | $ 131.49B |
| Cash Flow | |||||
| Free Cash Flow | $ 27.98B | $ 40.38B | $ 29.31B | $ 5.84B | $ 10.77B |
| Operating Cash Flow | $ 40.54B | $ 50.69B | $ 37.57B | $ 14.13B | $ 30.17B |
| Investing Cash Flow | $ -13.37B | $ -68.03B | $ 8.04B | $ -28.25B | $ -22.81B |
| Financing Cash Flow | $ -26.30B | $ 1.78B | $ -29.31B | $ 13.12B | $ -5.03B |
Currency in KRW